Stakeholders have until 30 August to comment on a pair of draft subsidiary regulations released by China’s National Medical Products Administration on 29 July following its publication of the final Cosmetics Supervision and Administration Regulation (CSAR) at the end of June.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?